AR061835A1 - TETRACICLIC DERIVATIVES, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - Google Patents

TETRACICLIC DERIVATIVES, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Info

Publication number
AR061835A1
AR061835A1 ARP070103012A ARP070103012A AR061835A1 AR 061835 A1 AR061835 A1 AR 061835A1 AR P070103012 A ARP070103012 A AR P070103012A AR P070103012 A ARP070103012 A AR P070103012A AR 061835 A1 AR061835 A1 AR 061835A1
Authority
AR
Argentina
Prior art keywords
branched
linear
group
alkyl group
atom
Prior art date
Application number
ARP070103012A
Other languages
Spanish (es)
Inventor
Catherine Dacquet
Veronique Leclerc
Helgoual Ch Jean-Martial L
Naour Morgan Le
Pascal Berthelot
Nicolas Lebegue
Pascal Carato
Alain Ktorza
Daniel-Henri Caignard
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of AR061835A1 publication Critical patent/AR061835A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Reivindicacion 1: Compuestos de formula (1) en la que: R1 representa un átomo de hidrogeno y R2 y R3 forman junto con los 2 átomos de carbono adyacentes a los que están unidos un ciclo de formula (2) en el que R6 representa un átomo de hidrogeno o de halogeno, o un grupo alquilo C1-6 lineal o ramificado, alcoxi C1-6 lineal o ramificado, amino, alquilamino C1-6 lineal o ramificado, o dialquilamino C1-6 lineal o ramificado, X representa un átomo de oxígeno o un grupo N-OR7 en el que R7 representa un átomo de hidrogeno o un grupo alquilo C1-6 lineal o ramificado, arilo, o arilalquilo C1-6 lineal o ramificado, o R3 representa un átomo de hidrogeno y R1 y R2 forman junto con los 2 átomos de carbono adyacentes a los que están unidos un ciclo de formula (2) tal como se ha definido anteriormente, R4 y R5, idénticos o diferentes, representan un átomo de hidrogeno o de halogeno, o un grupo alquilo C1-6 lineal o ramificado, alcoxi C1-6 lineal o ramificado, amino, alquilamino C1-6 lineal o ramificado, o dialquilamino C1-6 lineal o ramificado, A representa una cadena alquileno C1-6 en la que un grupo CH2 puede reemplazarse por un heteroátomo elegido entre oxígeno o azufre, o por un grupo NRa (en el que Ra representa un átomo de hidrogeno o un grupo alquilo C1-6 lineal o ramificado), B representa un grupo alquilo C1-6) lineal o ramificado, o alquenilo C2-6 lineal o ramificado, estando sustituidos estos grupos con un grupo de formula (3) en la que R8 representa un grupo - COOR y R9 representa un grupo -OR' en el que R y R', idénticos o diferentes, representan cada uno un átomo de hidrogeno, o un grupo alquilo C1-6 lineal o ramificado no sustituido o sustituido con uno o varios átomos de halogeno, entendiéndose que: la oxima =N-OR7 puede tener configuracion Z o E, por arilo se entiende un grupo fenilo, naftilo o bifenilo, pudiendo estar estos grupos parcialmente hidrogenados, por heteroarilo se entiende cualquier grupo aromático mono o bicíclico que contiene 5 a 10 eslabones, pudiendo estar parcialmente hidrogenado en uno de los ciclos en el caso de los heteroarilos bicíclicos, y que contiene 1 a 3 heteroátomos elegidos entre oxigeno, nitrogeno y azufre, pudiendo estar sustituidos los grupos arilo y heteroarilo así definidos con 1 a 3 grupos elegidos entre alquilo C1-6 lineal o ramificado, polihalogenoalquilo C1-6 lineal o ramificado, alcoxi C1-6 lineal o ramificado, hidroxi carboxi, formilo, NRbRc (en el que Rb, y Rc, idénticos o diferentes, representan un átomo de hidrogeno, un grupo alquilo C1-6 lineal o ramificado, arilo o heteroarilo), éster, amido, nitro, ciano, o átomos de halogeno, sus enantiomeros y diastereoisomeros así como sus sales de adicion a un ácido o a una base farmacéuticamente aceptables.Claim 1: Compounds of formula (1) in which: R1 represents a hydrogen atom and R2 and R3 together with the 2 adjacent carbon atoms to which a cycle of formula (2) is attached in which R6 represents a hydrogen or halogen atom, or a linear or branched C1-6 alkyl group, linear or branched C1-6 alkoxy, amino, linear or branched C1-6 alkylamino, or linear or branched C1-6 dialkylamino, X represents an atom of oxygen or an N-OR7 group in which R7 represents a hydrogen atom or a linear or branched C1-6 alkyl, aryl, or linear or branched C1-6 arylalkyl group, or R3 represents a hydrogen atom and R1 and R2 form together with the 2 adjacent carbon atoms to which a cycle of formula (2) is attached as defined above, R4 and R5, identical or different, represent a hydrogen or halogen atom, or a C1- alkyl group 6 linear or branched, C1-6 linear or branched alkoxy, amino, C1-6 alkylamino line al or branched, or linear or branched C1-6 dialkylamino, A represents a C1-6 alkylene chain in which a CH2 group can be replaced by a heteroatom chosen from oxygen or sulfur, or by a NRa group (in which Ra represents a hydrogen atom or a linear or branched C1-6 alkyl group, B represents a linear or branched C1-6 alkyl group, or linear or branched C2-6 alkenyl, these groups being substituted with a group of formula (3) in which R8 represents a group - COOR and R9 represents a group -OR 'in which R and R', identical or different, each represent a hydrogen atom, or a linear or branched C1-6 alkyl group unsubstituted or substituted with one or several halogen atoms, it being understood that: the oxime = N-OR7 may have Z or E configuration, by aryl a phenyl, naphthyl or biphenyl group is understood, these groups being partially hydrogenated, heteroaryl is any aromatic group mono or bicyclic containing 5 at 10 links, being able to be partially hydrogenated in one of the cycles in the case of bicyclic heteroaryls, and containing 1 to 3 heteroatoms chosen from oxygen, nitrogen and sulfur, being able to substitute the aryl and heteroaryl groups thus defined with 1 to 3 groups chosen from linear or branched C1-6 alkyl, linear or branched C1-6 polyhalogenoalkyl, linear or branched C1-6 alkoxy, carboxy hydroxy, formyl, NRbRc (in which Rb, and Rc, identical or different, represent an atom of hydrogen, a linear or branched C1-6 alkyl group, aryl or heteroaryl), ester, amido, nitro, cyano, or halogen atoms, their enantiomers and diastereoisomers as well as their pharmaceutically acceptable acid or base addition salts.

ARP070103012A 2006-07-10 2007-07-06 TETRACICLIC DERIVATIVES, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AR061835A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0606247A FR2903404B1 (en) 2006-07-10 2006-07-10 NOVEL TETRACYCLIC DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME

Publications (1)

Publication Number Publication Date
AR061835A1 true AR061835A1 (en) 2008-09-24

Family

ID=37722239

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070103012A AR061835A1 (en) 2006-07-10 2007-07-06 TETRACICLIC DERIVATIVES, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Country Status (3)

Country Link
AR (1) AR061835A1 (en)
FR (1) FR2903404B1 (en)
WO (1) WO2008006969A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2025674A1 (en) 2007-08-15 2009-02-18 sanofi-aventis Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs
WO2011107494A1 (en) 2010-03-03 2011-09-09 Sanofi Novel aromatic glycoside derivatives, medicaments containing said compounds, and the use thereof
DE102010015123A1 (en) 2010-04-16 2011-10-20 Sanofi-Aventis Deutschland Gmbh New benzylamidic diphenylazetidinone compounds, useful for treating lipid disorders, hyperlipidemia, atherosclerotic manifestations or insulin resistance, and for reducing serum cholesterol levels
EP2582709B1 (en) 2010-06-18 2018-01-24 Sanofi Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013068486A1 (en) 2011-11-08 2013-05-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the diagnosis and treatment of male infertility

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2804431A1 (en) * 2000-02-02 2001-08-03 Adir NEW HETEROCYCLIC DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2858321B1 (en) * 2003-07-28 2006-01-20 Servier Lab NOVEL HETEROCYCLIC OXIMIC DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME

Also Published As

Publication number Publication date
WO2008006969A2 (en) 2008-01-17
FR2903404A1 (en) 2008-01-11
FR2903404B1 (en) 2008-08-22
WO2008006969A3 (en) 2008-05-15

Similar Documents

Publication Publication Date Title
AR061835A1 (en) TETRACICLIC DERIVATIVES, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR063988A1 (en) HETEROCICLIC DERIVATIVES, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR061739A1 (en) NEW NAFTALENIC DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR062677A1 (en) DERIVATIVES OF BIARIL-SULFONAMIDE, PRODUCTION PROCESSES AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM
AR013494A1 (en) DERIVATIVES OF CARBOXAMIDOTIAZOLES, THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
AR089774A1 (en) DERIVATIVES OF INDOLIZINE, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
NI201000022A (en) NEW 6-TRIAZOLOPYRIDACINE-SULFANIL BENZOTHIAZOLE AND BENZHIMIDAZOLE DERIVATIVES, THEIR PREPARATION PROCEDURE, THEIR APPLICATION AS MEDICINES, PHARMACEUTICAL COMPOSITIONS AND NEW USE MAINLY AS MET INHIBITORS.
AR075892A1 (en) DERIVATIVES OF BENZOTIADIAZEPINAS, ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR033379A1 (en) DIFENILUREA COMPOUNDS, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR061377A1 (en) DIAZENIODIOLATE DERIVATIVES, PREPARATION PROCEDURE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USES IN CARDIOVASCULAR PATHOLOGIES.
AR069643A1 (en) DIAZENIDIOLATE DERIVATIVES, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CU20100157A7 (en) NEW DIHYDROINDOLONE DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR054121A1 (en) PHENYL PIRIDYL PIPERAZINE COMPOUNDS, PREPARATION PROCEDURE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PHARMACOLOGICAL USES AS ANTAGONIST OF HISTAMINERGIC RECEPTORS H3
GT200700084A (en) DERIVATIVES OF INDANIL-PIPERAZINAS, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
AR041883A1 (en) PIRIDOPIRIMIDINONE COMPOUNDS, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR052663A1 (en) HETEROCICLIC OXYM COMPOUNDS, A PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR045125A1 (en) HETEROCICLIC OXYM COMPOUNDS, PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR072103A1 (en) DERIVATIVES OF (PIPERAZINILO WITH BRIDGE LINKS) -1- ALCANONA, ITS USE AS P75 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR054120A1 (en) PHENYL PIRIDYL PIPERAZINE COMPOUNDS, PREPARATION PROCEDURE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PHARMACOLOGICAL USES AS ANTAGONIST OF HISTAMINERGIC RECEPTORS H3
AR052802A1 (en) BENZOTIAZINE AND BENZOTIADIAZINE COMPOUNDS A PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR072486A1 (en) CYCLE-RENTED BENZOTIADIAZINE DERIVATIVES THEIR PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR050542A1 (en) IMIDAZOPIRIDINE COMPOUNDS PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR044672A1 (en) BENZOTIAZINE AND BENZOTIADIAZINE COMPOUNDS, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR077492A1 (en) USEFUL CHROMENIC DERIVATIVES FOR THE TREATMENT OF PSYCHIATRIC AND NEUROLOGICAL DISEASES, PROCEDURE TO PREPARE THEM AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM.
AR041758A1 (en) COMPOUNDS OF 2,3-DIHIDRO-4 (1H) -PIRIDONE, PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Legal Events

Date Code Title Description
FB Suspension of granting procedure